Boundless Bio enters $14.5M ATM equity distribution agreement with Jefferies

Boundless Bio, Inc.

Company may sell up to $14.5M of common stock via at-the-market offerings through Jefferies LLC.
Shares sold at prevailing market prices; Jefferies receives up to 3.0% commission on gross proceeds.
No minimum sale obligation; either party may terminate the agreement on prior written notice.
Issuance is subject to SEC effectiveness of Form S-3 registration statement filed April 1, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.